Bioceres Crop Solutions Corp. (BIOX)

Market Cap	34.35M -86.8%
Revenue (ttm)	276.60M -32.2%
Net Income	-239.56M
EPS	-3.77
Shares Out	63.48M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	360,366
Open	0.5915
Previous Close	0.5919
Day's Range	0.5400 - 0.6187
52-Week Range	0.3472 - 5.1750
Beta	0.53
Analysts	Buy
Price Target	4.33 (+700.07%)
Earnings Date	May 19, 2026

About BIOX

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, comm...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2001
• Employees: 751
• Stock Exchange: NASDAQ
• Ticker Symbol: BIOX

Analyst Summary

According to 3 analysts, the average rating for BIOX stock is "Buy." The 12-month stock price target is $4.33, which is an increase of 700.07% from the latest price.

Price Target

$4.33

(700.07% upside)

Analyst Consensus: Buy